Tenon Medical (TNON) to Release Earnings on Thursday

Tenon Medical (NASDAQ:TNON) is expected to release its Q4 2025 results after the market closes on Thursday, March 19th. Analysts expect Tenon Medical to post earnings of ($0.36) per share and revenue of $1.3780 million for the quarter. Interested persons are encouraged to explore the company’s upcoming Q4 2025 earning overview page for the latest details on the call scheduled for Thursday, March 19, 2026 at 4:30 PM ET.

Tenon Medical Stock Down 9.1%

TNON stock opened at $0.79 on Wednesday. The firm has a market cap of $8.78 million, a PE ratio of -0.45 and a beta of 1.25. The business has a 50 day moving average of $0.85 and a 200-day moving average of $1.04. Tenon Medical has a 12-month low of $0.64 and a 12-month high of $5.85.

Institutional Trading of Tenon Medical

Several large investors have recently modified their holdings of the company. DRW Securities LLC purchased a new stake in Tenon Medical during the fourth quarter valued at $98,000. Geode Capital Management LLC grew its stake in shares of Tenon Medical by 34.6% during the 4th quarter. Geode Capital Management LLC now owns 66,640 shares of the company’s stock valued at $63,000 after purchasing an additional 17,137 shares during the period. Finally, Jane Street Group LLC bought a new stake in shares of Tenon Medical during the 1st quarter valued at about $29,000. Institutional investors own 22.74% of the company’s stock.

Analyst Ratings Changes

Separately, Weiss Ratings reiterated a “sell (e+)” rating on shares of Tenon Medical in a report on Wednesday, January 21st. Two equities research analysts have rated the stock with a Buy rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat, Tenon Medical presently has a consensus rating of “Hold” and a consensus price target of $3.00.

Tenon Medical Company Profile

Tenon Medical, Inc is a development-stage medical device company focused on the research, development and commercialization of next-generation surgical biologic adhesives and sealants. The company’s proprietary platform is designed to create tissue-compatible adhesives that can serve as alternatives or complements to traditional sutures and staples, with the goal of improving surgical efficiency, reducing postoperative complications and enhancing patient outcomes.

Tenon Medical’s product pipeline centers on protein-based polymer formulations that cross-link in situ to form a flexible, yet durable, bond with native tissue.